BioStorage Technologies

Gregory Swanberg has been named chief executive officer of BioStorage Technologies, effective immediately. Dr. F. John Mills, M.D., Ph.D., will step down from that role but will continue to serve as chairman of the board.

Mr. Swanberg has more than 25 years of senior management and executive experience leading operational, sales and corporate support teams. His management experience includes directly overseeing the technical delivery of global outsourced services for critical functions in pharmaceutical manufacturing facilities, public and private research centers, hospitals and clinics and data centers. He has provided management and consulting support domestically and globally for companies like Pfizer, Merck, Genentech, Novartis, Lilly, Morgan Stanley, AT&T, Whirlpool and Lexmark. Mr. Swanberg most recently served as the managing director of UMS Advisory, a firm focused on outsourcing and operational excellence primarily in the life science sector.

Dr. Mills commented, “Greg’s strong track record in leading organizations within healthcare will provide new avenues of expansion that I’m confident will bring tremendous value to BioStorage Technologies and our customers.”

Dr. Mills has led BioStorage Technologies’ strategic direction since co-founding the company in 2003. Mr. Swanberg’s appointment is part of the company’s long-term management succession plan.